v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - OMFC - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 567 $ 914
Investment securities (includes available-for-sale securities with a fair value and an amortized cost basis of $1.6 billion and $1.7 billion in 2026, respectively, and $1.5 billion and $1.6 billion in 2025, respectively) 1,649 1,590
Net finance receivables (includes loans of consolidated VIEs of $14.1 billion in 2026 and $13.4 billion in 2025) 25,145 24,833
Unearned insurance premium and claim reserves (792) (791)
Allowance for finance receivable losses (includes allowance of consolidated VIEs of $1.6 billion in 2026 and $1.6 billion in 2025) (2,923) (2,865)
Net finance receivables, less unearned insurance premium and claim reserves and allowance for finance receivable losses 21,430 21,177
Restricted cash and restricted cash equivalents (includes restricted cash and restricted cash equivalents of consolidated VIEs of $724 million in 2026 and $690 million in 2025) 738 699
Goodwill 1,474 1,474
Other intangible assets 279 282
Other assets 1,287 1,252
Total assets 27,424 27,388
Liabilities and Shareholders’ Equity    
Long-term debt (includes debt of consolidated VIEs of $12.0 billion in 2026 and $11.5 billion in 2025) 22,769 22,694
Insurance claims and policyholder liabilities 552 576
Deferred and accrued taxes 16 35
Other liabilities (includes other liabilities of consolidated VIEs of $31 million in 2026 and $30 million in 2025) 704 682
Total liabilities 24,041 23,987
Contingencies (Note 12)
Shareholders’ equity:    
Common stock, par value $0.50 per share; 25,000,000 shares authorized, 10,160,021 shares issued and outstanding at June 30, 2026 and December 31, 2025 1 1
Additional paid-in capital 1,758 1,757
Accumulated other comprehensive loss (54) (41)
Retained earnings 2,710 2,579
Total shareholders’ equity 3,383 3,401
Total liabilities and shareholders’ equity 27,424 27,388
OMFC    
Assets    
Cash and cash equivalents 557 898
Investment securities (includes available-for-sale securities with a fair value and an amortized cost basis of $1.6 billion and $1.7 billion in 2026, respectively, and $1.5 billion and $1.6 billion in 2025, respectively) 1,649 1,590
Net finance receivables (includes loans of consolidated VIEs of $14.1 billion in 2026 and $13.4 billion in 2025) 25,145 24,833
Unearned insurance premium and claim reserves (792) (791)
Allowance for finance receivable losses (includes allowance of consolidated VIEs of $1.6 billion in 2026 and $1.6 billion in 2025) (2,923) (2,865)
Net finance receivables, less unearned insurance premium and claim reserves and allowance for finance receivable losses 21,430 21,177
Restricted cash and restricted cash equivalents (includes restricted cash and restricted cash equivalents of consolidated VIEs of $724 million in 2026 and $690 million in 2025) 738 699
Goodwill 1,474 1,474
Other intangible assets 279 282
Other assets 1,286 1,252
Total assets 27,413 27,372
Liabilities and Shareholders’ Equity    
Long-term debt (includes debt of consolidated VIEs of $12.0 billion in 2026 and $11.5 billion in 2025) 22,769 22,694
Insurance claims and policyholder liabilities 552 576
Deferred and accrued taxes 16 36
Other liabilities (includes other liabilities of consolidated VIEs of $31 million in 2026 and $30 million in 2025) 701 682
Total liabilities 24,038 23,988
Contingencies (Note 12)
Shareholders’ equity:    
Common stock, par value $0.50 per share; 25,000,000 shares authorized, 10,160,021 shares issued and outstanding at June 30, 2026 and December 31, 2025 5 5
Additional paid-in capital 2,002 2,001
Accumulated other comprehensive loss (54) (41)
Retained earnings 1,422 1,419
Total shareholders’ equity 3,375 3,384
Total liabilities and shareholders’ equity $ 27,413 $ 27,372